Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

12-months of Treatment With Burosumab in Children and Adolescents With X-linked Hypophosphatemia: a Prospective Longitudinal Cohort Study

NCT04419363 is registered in ClinicalTrials.gov with Bicetre Hospital as lead sponsor.

NCT NCT04419363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04419363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
12-months of Treatment With Burosumab in Children and Adolescents With X-linked Hypophosphatemia: a Prospective Longitudinal Cohort Study
Lead sponsor
Bicetre Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 18, 2018
Completion date
September 16, 2022
Enrollment
57 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rare diseases, x-linked hypophosphatemia